The Platelet-to-Lymphocyte Ratio combines two cheap, routine CBC values into a systemic inflammation and immune-stress marker. It's been extensively validated across oncology, cardiology, and autoimmune disease literature.
Elevated PLR independently predicts cardiovascular events, cancer mortality, and worse prognosis in many inflammatory diseases, often at a level comparable to more expensive inflammation markers. A useful integrator alongside NLR and hs-CRP.
Optimal Platelet:Lymphocyte Ratio: 80-150 ratio.
Typically re-tested every 8 weeks.
Because both numbers already appear on a routine blood count, the ratio costs nothing extra to obtain. Its value comes from being tracked over time rather than read once.
The platelet:lymphocyte ratio is a single derived number produced by dividing your platelet count by your absolute lymphocyte count, both reported on a complete blood count with differential.
The mechanism behind it rests on what those two cell lines actually do. Platelets are not only clotting cells. They store and release cytokines, chemokines and growth factors, they stick to damaged blood vessel linings, and they form complexes with white blood cells during inflammatory signalling. When inflammatory messengers such as interleukin-6 rise, the bone marrow tends to produce more platelets, a pattern labs regard as reactive thrombocytosis.
Lymphocytes sit on the other side of the equation. T cells, B cells and natural killer cells carry out targeted, regulated immune work, and their numbers in circulating blood fall during periods of physiological stress, partly because cortisol redistributes them out of the bloodstream and into tissues.
So the two components tend to move in opposite directions under inflammatory or physiological stress. Platelets drift up, circulating lymphocytes drift down, and the ratio between them amplifies a change that either number alone might under-report. That amplification is the entire argument for using a ratio rather than two separate counts, and it is why researchers have described this marker as a simple, inexpensive and rapid prognostic signal in cardiovascular settings 1.
The number is unitless, as long as both counts are expressed in the same units. A platelet count of 250 x 10⁹/L with an absolute lymphocyte count of 2.0 x 10⁹/L gives a ratio of 125.
The broadest body of work sits in cardiovascular medicine, where studies indicate the ratio carries prognostic information for cardiovascular events 1. In acute illness, research in sepsis and septic shock has examined the ratio alongside lactate in relation to mortality 2, and work in hospitalised COVID-19 patients assessed it next to C-reactive protein to albumin and lymphocyte to monocyte ratios as a mortality-associated signal 3.
A study of operable pancreatic ductal adenocarcinoma examined preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in relation to long-term survival 4, and a systematic review assessed its prognostic value in glioblastoma 5.
Two caveats keep this honest. First, almost all of that evidence comes from hospital or disease populations, where the ratio is being used to stratify risk among people who are already unwell. Second, association is not causation. Nothing suggests that nudging the ratio itself changes an outcome. For a generally healthy adult tracking their own biology, this marker is best understood as a low-cost trend line on systemic inflammation, not a risk score, and not a screening test for any specific disease.
Most laboratories regard values of roughly 50 to 200 as a typical reference range for this calculated ratio, while FitScript's optimal range is narrower.
| Reference | Range | What it represents |
|---|---|---|
| Typical lab reference range | 50 to 200 | The spread seen across general adult populations on routine blood counts |
| FitScript optimal range | 80 to 150 | FitScript's optimization target for a stable, low-inflammation profile |
FitScript's optimal range is an optimization target, not a diagnostic cut-off, and sitting outside it does not indicate disease. Reference ranges vary by laboratory, by age and by sex, and because this ratio is calculated rather than directly measured, few labs publish a validated range of their own. Always read your result against the range printed on your own report.
No sex-specific or age-specific optimal ranges are published for this marker here, so treat a single number as one data point among many. The trend across repeated tests carries more information than any individual result.
A high result means your platelet count is elevated relative to your circulating lymphocyte count, a pattern commonly seen when inflammatory signalling is active or when physiological stress has suppressed lymphocyte numbers.
What people report. The ratio itself produces no symptoms. People whose results sit high alongside other inflammatory markers often describe fatigue that sleep does not fix, slow recovery from training, low-grade joint stiffness, foggy thinking, disturbed sleep or flattened mood. Research has examined these ratios in mood disorders, with findings suggesting an association between inflammatory ratios and depressive and bipolar presentations 6, and a prospective observational study looked at the same family of ratios in relation to postpartum depression 7. None of that makes the ratio a test for mood.
Common drivers. A recent or ongoing infection is the most frequent explanation, and the effect can persist for weeks after symptoms settle. Other common contributors include chronic inflammatory conditions such as rheumatoid arthritis or inflammatory bowel disease, recent surgery or significant bleeding, iron deficiency (which can raise platelet production), sustained psychological or training stress, smoking, higher visceral fat mass, and pregnancy. In people with severe preeclampsia, research has examined mean platelet volume alongside neutrophil-lymphocyte and platelet-lymphocyte ratios 8. The ratio has also been studied in acute events, including stroke-associated pneumonia in a systematic review and meta-analysis 9 and sudden sensorineural hearing loss 10.
Longer-term signal. Research has linked a raised ratio to cardiovascular events 1 and, in one study, to radiographic severity of hip osteoarthritis alongside mean platelet volume 11.
What is worth doing. A single high reading taken near an illness usually warrants nothing more than a repeat test once you are well. A value that stays suboptimal across several draws, especially alongside a raised C-reactive protein, is worth reviewing with a clinician who can look at the underlying counts. A markedly raised result accompanied by fever, unexplained weight loss, night sweats or persistent swollen lymph nodes is worth discussing with a clinician promptly.
A low result means platelets are low relative to lymphocytes, which happens either because the platelet count has fallen, because the lymphocyte count has risen, or both.
What people report. Most people notice nothing. Where the platelet count is genuinely low, people sometimes report easy bruising, small red pinpoint spots on the skin, bleeding gums, nosebleeds that take longer to stop, or heavier menstrual bleeding. Where lymphocytes are elevated, a recent viral illness, sore throat or swollen glands may be the obvious explanation.
Common drivers. On the platelet side, labs consider liver disease, heavy alcohol intake, vitamin B12 or folate deficiency, autoimmune platelet destruction, certain medication effects, and laboratory artefact from platelet clumping in the collection tube. On the lymphocyte side, recent viral infection (Epstein-Barr virus is a classic example), some chronic infections, and lymphoproliferative conditions all raise counts. Well-trained endurance athletes and younger adults also tend to sit lower than average without anything being wrong.
Longer-term signal. A low ratio is not described in the research as protective, and it has been studied far less than a high one. Its main value is directional. It tells you to stop looking at the ratio and start looking at its two components, because a meaningfully low platelet count or a persistently high lymphocyte count each carry their own interpretation.
What is worth doing. Check the absolute platelet and lymphocyte counts on the same report. If the platelet count is below the lab's reference range, or if bruising or unusual bleeding is present, that is worth discussing with a clinician promptly rather than waiting for the next test.
Quite a lot, which is why one reading rarely settles anything.
Testing conditions. Acute infection in the preceding weeks is the single largest short-term influence. Hard or prolonged exercise shortly before a draw shifts circulating lymphocyte numbers temporarily. Cortisol follows a daily rhythm, so morning and afternoon samples are not strictly comparable. Dehydration, prolonged tourniquet time, recent vaccination, pregnancy, smoking shortly before a draw and living at altitude can all move one or both counts. Platelet clumping in EDTA tubes can produce a falsely low platelet count and therefore a falsely low ratio, a known artefact that a repeat draw usually resolves.
Medications. Several common drugs can lower platelet counts. Never stop or change a prescribed medication because of a lab value. Tell whoever reviews your results exactly what you take, including supplements, so the number is read in context.
For the cleanest comparison between tests, book draws in the morning, in a similar fasted state, at least a few days clear of heavy training and at least a few weeks clear of any acute illness.
The ratio is calculated from a complete blood count with differential, the same routine test that reports platelets, neutrophils and lymphocytes, so no separate test is needed.
FitScript's membership covers 150+ biomarkers tested per year, which means the blood count repeats across the year and this ratio can be read as a trend line rather than a snapshot. That matters more here than for most markers, because a single value is so easily distorted by a recent infection or a hard training block.
Atlas, FitScript's AI health advisor, reads the result in the context of the full panel, pairing it with the underlying cell counts and other inflammatory markers before writing your FitScript, the personalized output built from your own biology. Where a prescription option might be considered, a licensed provider evaluates whether it is appropriate after reviewing the member, their history and their labs. No lab value on its own leads to a prescription.
This ratio is close to uninterpretable in isolation, so read it with the markers that explain it.
Start with its two ingredients. Platelets tell you whether a raised ratio reflects reactive platelet production or something else, and Lymphocytes Absolute tells you whether the denominator has fallen. A ratio can shift substantially while both counts stay inside their own reference ranges, and only the components reveal which side moved.
Neutrophil:Lymphocyte Ratio is the companion marker in almost every published study of this family, including the stroke-associated pneumonia meta-analysis 9 and the pancreatic surgery survival work 4. Where both ratios move together, the inflammatory signal is more convincing than when only one does.
C-Reactive Protein is the most direct acute-phase inflammatory marker and has been studied alongside this ratio in hospitalised patients 3. Fibrinogen Activity adds a clotting-side view of the same acute-phase response, and Homocysteine covers a separate vascular pathway influenced by B vitamin status. Mean platelet volume, reported on most blood counts, is also worth a glance, since it was examined alongside the ratio in hip osteoarthritis research 11.
The platelet:lymphocyte ratio is a free by-product of a test you are probably already having. It rises when platelet-driven inflammatory activity outweighs lymphocyte-driven regulation, falls when the reverse is true, and carries real prognostic information in clinical populations while remaining a broad trend marker in healthy ones. Read it with its components, read it over time, and read it alongside C-reactive protein rather than alone.
This article is educational information and not medical advice. Discuss your results, and any treatment, with a clinician or licensed provider who can see your full history.
The complete blood count that produces this ratio, along with the other markers above, is part of the FitScript Essential panel.
Divide the platelet count by the absolute lymphocyte count, using the same units for both. A platelet count of 250 x 10⁹/L with an absolute lymphocyte count of 2.0 x 10⁹/L gives a ratio of 125. Both numbers come from a standard complete blood count with differential, so no extra test or extra blood draw is required.
Most laboratories regard roughly 50 to 200 as a typical reference range for adults, and FitScript's optimal range is 80 to 150. FitScript's optimal range is an optimization target rather than a diagnostic cut-off. Because the ratio is calculated rather than directly measured, few labs publish a validated range of their own, so read your result against your own report.
Not by itself. A raised value suggests platelet activity is high relative to circulating lymphocytes, a pattern commonly seen during or after infection, physiological stress or active inflammation. It can also reflect iron deficiency or recent surgery. One value is never enough to conclude anything, so repeat the test when well and review it alongside C-reactive protein and the underlying cell counts with a clinician.
Yes, temporarily. Hard or prolonged exercise shifts circulating lymphocyte numbers for a period afterwards, which can push the ratio up without any lasting change in inflammation. For comparable results between tests, schedule blood draws in the morning, in a similar fasted state, and at least a few days clear of a heavy training session or a long endurance effort.
It means platelets are low relative to lymphocytes, either because the platelet count has fallen or the lymphocyte count has risen. Causes labs consider include recent viral infection, liver disease, heavy alcohol intake, B12 or folate deficiency, medication effects and laboratory platelet clumping. The useful next step is to look at the two component counts rather than the ratio itself.
No. It is not a screening test for any disease.
There is no fixed schedule, and the right interval depends on why you are tracking it. Because the value moves with recent illness, stress and training, the trend across several draws over months is far more informative than any single reading. FitScript's membership covers 150+ biomarkers tested per year, so the blood count that produces this ratio repeats across the year.